Inhibition of Soluble Epoxide Hydrolase Reduces Inflammation and Myocardial Injury in Arrhythmogenic Cardiomyopathy
Dipak Panigrahy(Beth Israel Deaconess Medical Center), Jeffrey E. Saffitz(Beth Israel Deaconess Medical Center), Angeliki Asimaki(St George's, University of London), Carlos Bueno‐Betí(Genomics (United Kingdom)), Darryl C. Zeldin(National Institute of Environmental Health Sciences), Vinay Penna(Washington University in St. Louis), Michael Allen Gillespie(Beth Israel Deaconess Medical Center), Isabella Howard(Beth Israel Deaconess Medical Center), Abigail Kelly(Beth Israel Deaconess Medical Center), Sung Hee Hwang(UC Davis Comprehensive Cancer Center), Weicang Wang(Purdue University West Lafayette), Katherine Quinlivan(Beth Israel Deaconess Medical Center), Matthew L Edin(Triangle), Jun Yang(UC Davis Comprehensive Cancer Center), Bruce D. Hammock(UC Davis Comprehensive Cancer Center), Kory J. Lavine(Washington University in St. Louis)
Cited by 5
Related Papers
Tissue Resident CCR2− and CCR2+ Cardiac Macrophages Differentially Orchestrate Monocyte Recruitment and Fate Specification Following Myocardial Injury
|Circulation Research|2019|717
Spatial multi-omic map of human myocardial infarction
|Nature|2022|692
In vivo endothelial siRNA delivery using polymeric nanoparticles with low molecular weight
|Nature Nanotechnology|2014|580
Diagnosis of arrhythmogenic cardiomyopathy: The Padua criteria
|International Journal of Cardiology|2020|557